Search filters

Polyneuron extends Series A Financing to CHF 36.5m

Polyneuron Pharmaceuticals AG extended its Series A by CHF 14m bringing the total to CHF 36.5m. Polyneuron is a clinical stage developer of a new class of antigen-specific polymers for the treatment of patients affected by...

AFINUM acquires Threema

AFINUM has acquired Threema GmbH, Freienbach (CH), the Swiss developer and provider of the leading European secure messenger solution for professional and personal communication. As part of this transaction, the three founders...

T3 Pharma closes 25M CHF financing round

T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech advancing immuno-oncology with its bacteria-based protein delivery platform, closed its third financing round, raising over 25M CHF. The financing was co-led by existing...

Polares Medical closes a USD40M financing for pilot clinical studies

Polares Medical SA, in Lausanne, a clinical stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR),...

Azafaros expands executive management team and operations

Azafaros B.V., headquartered in Leiden, The Netherlands, has recently incorporated a Swiss subsidiary in the pharma hub of Basel to strengthen its research and development operations. In addition, three experienced industry...

FoRx Therapeutics AG raises EUR 10M Seed-Financing round

FoRx Therapeutics AG, a Basel-based biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways activated in cancer, completes a EUR 10M seed-financing round led by M...

V-Labs SA closes a significant "angel" financing round

V-Labs SA (former v-Labs Sàrl) has raised a significant angel investment to further grow its business and bring its innovative Augmented Reality product for surveying and construction works to the market. VISCHER has been...

NBE-Therapeutics closes USD 22M Series C financing round

NBE-Therapeutics AG closed a USD 22M Series C financing round, led by its existing shareholders Boehringer Ingelheim Venture Fund and the PPF Group and with participation from all private shareholders. The funds will enable NBE to...

Oviva raises USD 21M to roll out digital diabetes treatment in Europe

Oviva raises USD 21M to roll out digital diabetes treatment in Europe.

The round was led by Swiss healthtech investor MTIP, joined by Earlybird as new investors. Existing investors AlbionVC, F-Prime Capital, Eight Roads Ventures...

Resistell Closes Series A Financing Round

Resistell AG has closed a milestone-based CHF 3.5M Series A Financing round led by OCCIDENT. TRUMPF Venture, Alpana Ventures, Zürcher Kantonalbank, HEMEX and seven private investors also back the start-up developing world’s...

You are currently offline. Some pages or content may fail to load.